経皮ドラッグデリバリーシステム市場- タイプ別、用途別、最終用途別＆予測、2023年～2032年

経皮ドラッグデリバリーシステムの世界市場は、非侵襲的なドラッグデリバリーシステムに対する需要の高まりにより、2023年から2032年にかけて適正なCAGRを示すと予想されています。

経口、局所、経皮などの非侵襲的なドラッグデリバリー法は、侵襲的な処置に比べて痛みがなく、副作用も少ないです。これらの特性は、長年にわたってこれらのシステムの人気を高め、自己投与への依存度が高い患者への採用を後押しし、投与回数の減少により患者のコンプライアンスを向上させています。

経皮ドラッグデリバリーシステム市場は、タイプ、用途、最終用途、地域によって分類されます。

タイプ別では、セミソリッドタイプの経皮吸収型製剤の市場規模が2032年まで拡大すると予測されています。スプレーのような半固体の経皮ドラッグデリバリー製品は、薬物を直接投与することができ、副作用が少ないのが特徴です。また、患者さんの治療効果を高めるために、事前に測定した用量を投与することができます。さらに、軟膏、ゲル、スプレーなど、さまざまな半固体経皮吸収型製剤が入手しやすいことも、2032年までの採用に有利に働くでしょう。

アプリケーションに関して、心血管疾患セグメントは2022年に19%以上の市場シェアを蓄積しました。世界的に心血管疾患（CVD）の有病率が高いことから、今後数年間は製品の普及が進むと考えられます。WHOによると、CVDは顕著な死因であり、全世界で年間約1,790万人が死亡しています。さらに、これらの疾患の治療において、非侵襲的なドラッグデリバリー機器が受け入れられるようになったことで、経皮ドラッグデリバリーシステム市場の成長見通しがさらに強固なものになると考えられます。

最終用途別では、在宅医療分野での経皮ドラッグデリバリーシステムが、2032年までに適正な評価額を記録する可能性があります。経皮ドラッグデリバリーシステムの最近の技術革新により、ホームケア用途での採用が促進されています。これらのドラッグデリバリーは、非経口投与に伴うリスクや不快感を軽減するため、在宅での使用に適しています。また、低侵襲な治療に対する需要の高まりも、長期的には製品の需要拡大に寄与するものと思われます。

アジア太平洋地域の経皮ドラッグデリバリーシステム市場は、2032年まで大幅に拡大すると予想されています。老年人口の増加と慢性疾患への感受性の高さが、この地域における経皮ドラッグデリバリーシステムへの需要を高めています。WHOによると、中国では2040年までに総人口の28％が60歳以上になるとされています。アジア太平洋地域には、久光製薬株式会社をはじめとする主要な業界企業が存在し、常に製品の革新に取り組んでいます。このことは、今後数年間の市場力学全体にも好影響を与えるでしょう。

目次

第1章 調査手法とスコープ

第2章 エグゼクティブサマリー

第3章 経皮ドラッグデリバリーシステム業界洞察

• 業界のセグメンテーション
• 業界情勢、2018年～2032年
• 業界への影響要因
  • 促進要因
    • 慢性疾患の有病率の増加
    • 経皮パッチの採用の増加
    • 非侵襲的なドラッグデリバリーシステムに対する需要の高まり
  • 業界の潜在的リスク＆課題
    • 承認された医薬品の数が限られている
    • ドラッグデリバリーシステムの開発にかかる高いコスト
• 成長可能性分析
  • タイプ別
  • 用途別
  • 最終用途別
• COVID-19の影響分析
• 規制状況
• 経皮ドラッグデリバリーシステムの進歩
• 特定活性物質を含む経皮吸収型製剤、%
• 価格分析、タイプ別、2022年
• ポーター分析
• PESTEL分析

第4章 競合情勢、2021年

• イントロダクション
• 企業マトリックス分析、2021年
• 各社のポジショニングマトリックス
• 主要市場プレイヤーの競合分析
• 戦略的展望マトリクス
• 戦略ダッシュボード、2021年

第5章 経皮ドラッグデリバリーシステム市場：タイプ別

• 主なタイプ別動向
• 経皮吸収型パッチ
  • ドラッグインアドヒーシブパッチ
  • マトリクスパッチ
  • リザーバーメンブメントパッチ
  • マイクロニードルパッチ
• 経皮吸収型半固形剤
  • ゲル
  • 軟膏剤
  • スプレー

第6章 経皮ドラッグデリバリーシステム市場：用途別

• 主なアプリケーション動向
• 疼痛管理
• ホルモン剤
• 中枢神経系疾患
• 心血管疾患
• その他

第7章 経皮ドラッグデリバリーシステム市場：最終用途別

• 主なエンドユースの動向
• 病院
• 診療所
• 在宅医療現場
• その他

第8章 経皮ドラッグデリバリーシステム市場：地域別動向

• 主な地域動向
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • ポーランド
  • スイス
  • オランダ
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • インドネシア
  • タイ
  • ベトナム
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
  • ペルー
  • コロンビア
• 中東・アフリカ地域
  • 南アフリカ共和国
  • サウジアラビア
  • UAE
  • イスラエル

第9章 企業プロファイル

• Novartis
• Mylan
• Amneal Pharmaceuticals, Inc
• Zydus Pharmaceuticals, Inc
• UCB
• Hisamitsu Pharmaceutical Co.,Inc
• Corium, Inc.
• Micropoint Technologies.
• Sparsha Pharma International Pvt. Ltd.
• Luye pharma

Data Tables

• TABLE 1. Market revenue, by type, 2022
• TABLE 2. Market share, by application, 2022
• TABLE 3. Market share, by end-use, 2022
• TABLE 4. Market share, by region, 2022
• TABLE 5. Global transdermal drug delivery systems market, 2018-2022 (USD Million)
• TABLE 6. Global transdermal drug delivery systems market, 2023 - 2032 (USD Million)
• TABLE 7. Global transdermal drug delivery systems market, by type, 2018-2022 (USD Million)
• TABLE 8. Global transdermal drug delivery systems market, by type, 2023 - 2032 (USD Million)
• TABLE 9. Global transdermal drug delivery systems market, by application, 2018-2022 (USD Million)
• TABLE 10. Global transdermal drug delivery systems market, by application, 2023 - 2032 (USD Million)
• TABLE 11. Global transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)
• TABLE 12. Global transdermal drug delivery systems market, by end-use, 2023 - 2032 (USD Million)
• TABLE 13. Global transdermal drug delivery systems market estimates and forecast, 2018-2022 (USD Million)
• TABLE 14. Global transdermal drug delivery systems market estimates and forecast, 2023 - 2032 (USD Million)
• TABLE 15. Industry impact forces
• TABLE 16. Transdermal patches market estimates and forecast, 2018-2022 (USD Million)
• TABLE 17. Transdermal patches market estimates and forecast, 2023 - 2032 (USD Million)
• TABLE 18. Drug-in-adhesive patches market estimates and forecast, 2018-2022 (USD Million)
• TABLE 19. Drug-in-adhesive patches market estimates and forecast, 2023 - 2032 (USD Million)
• TABLE 20. Matrix patches market estimates and forecast, 2018-2022 (USD Million)
• TABLE 21. Matrix patches market estimates and forecast, 2023 - 2032 (USD Million)
• TABLE 22. Reservoir membrane patches market estimates and forecast, 2018-2022 (USD Million)
• TABLE 23. Reservoir membrane patches market estimates and forecast, 2023 - 2032 (USD Million)
• TABLE 24. Microneedle patches market estimates and forecast, 2018-2022 (USD Million)
• TABLE 25. Microneedle patches market estimates and forecast, 2023 - 2032 (USD Million)
• TABLE 26. Transdermal semisolids market estimates and forecast, 2018-2022 (USD Million)
• TABLE 27. Transdermal semisolids market estimates and forecast, 2023 - 2032 (USD Million)
• TABLE 28. Gels market estimates and forecast, 2018-2022 (USD Million)
• TABLE 29. Gels market estimates and forecast, 2023 - 2032 (USD Million)
• TABLE 30. Ointments market estimates and forecast, 2018-2022 (USD Million)
• TABLE 31. Ointments market estimates and forecast, 2023 - 2032 (USD Million)
• TABLE 32. Sprays market estimates and forecast, 2018-2022 (USD Million)
• TABLE 33. Sprays market estimates and forecast, 2023 - 2032 (USD Million)
• TABLE 34. Pain management market estimates and forecast, 2018-2022 (USD Million)
• TABLE 35. Pain management market estimates and forecast, 2023 - 2032 (USD Million)
• TABLE 36. Hormonal applications market estimates and forecast, 2018-2022 (USD Million)
• TABLE 37. Hormonal applications market estimates and forecast, 2023 - 2032 (USD Million)
• TABLE 38. Central nervous system disorders market estimates and forecast, 2018-2022 (USD Million)
• TABLE 39. Central nervous system disorders market estimates and forecast, 2023 - 2032 (USD Million)
• TABLE 40. Cardiovascular diseases market estimates and forecast, 2018-2022 (USD Million)
• TABLE 41. Cardiovascular diseases market estimates and forecast, 2023 - 2032 (USD Million)
• TABLE 42. Others market estimates and forecast, 2018-2022 (USD Million)
• TABLE 43. Others market estimates and forecast, 2023 - 2032 (USD Million)
• TABLE 44. Hospitals market estimates and forecast, 2018-2022 (USD Million)
• TABLE 45. Hospitals market estimates and forecast, 2023 - 2032 (USD Million)
• TABLE 46. Clinics market estimates and forecast, 2018-2022 (USD Million)
• TABLE 47. Clinics market estimates and forecast, 2023 - 2032 (USD Million)
• TABLE 48. Home care settings market estimates and forecast, 2018-2022 (USD Million)
• TABLE 49. Home care settings market estimates and forecast, 2023 - 2032 (USD Million)
• TABLE 50. Others market estimates and forecast, 2018-2022 (USD Million)
• TABLE 51. Others market estimates and forecast, 2023 - 2032 (USD Million)
• TABLE 52. North America transdermal drug delivery systems market, by country, 2018-2022 (USD Million)
• TABLE 53. North America transdermal drug delivery systems market, by country, 2023 - 2032 (USD Million)
• TABLE 54. North America transdermal drug delivery systems market, by type, 2018-2022 (USD Million)
• TABLE 55. North America transdermal drug delivery systems market, by type, 2023 - 2032 (USD Million)
• TABLE 56. North America transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)
• TABLE 57. North America transdermal drug delivery systems market, by transdermal patches, 2023-2032 (USD Million)
• TABLE 58. North America transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)
• TABLE 59. North America transdermal drug delivery systems market, by transdermal semisolids, 2023-2032 (USD Million)
• TABLE 60. North America transdermal drug delivery systems market, by application, 2018-2022 (USD Million)
• TABLE 61. North America transdermal drug delivery systems market, by application, 2023 - 2032 (USD Million)
• TABLE 62. North America transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)
• TABLE 63. North America transdermal drug delivery systems market, by end-use, 2023 - 2032 (USD Million)
• TABLE 64. U.S. transdermal drug delivery systems market, by type, 2018-2022 (USD Million)
• TABLE 65. U.S. transdermal drug delivery systems market, by type, 2023 - 2032 (USD Million)
• TABLE 66. U.S. transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)
• TABLE 67. U.S. transdermal drug delivery systems market, by transdermal patches, 2023-2032 (USD Million)
• TABLE 68. U.S. transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)
• TABLE 69. U.S. transdermal drug delivery systems market, by transdermal semisolids, 2023-2032 (USD Million)
• TABLE 70. U.S. transdermal drug delivery systems market, by application, 2018-2022 (USD Million)
• TABLE 71. U.S. transdermal drug delivery systems market, by application, 2023 - 2032 (USD Million)
• TABLE 72. U.S. transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)
• TABLE 73. U.S. transdermal drug delivery systems market, by end-use, 2023 - 2032 (USD Million)
• TABLE 74. Canada transdermal drug delivery systems market, by type, 2018-2022 (USD Million)
• TABLE 75. Canada transdermal drug delivery systems market, by type, 2023 - 2032 (USD Million)
• TABLE 76. Canada transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)
• TABLE 77. Canada transdermal drug delivery systems market, by transdermal patches, 2023-2032 (USD Million)
• TABLE 78. Canada transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)
• TABLE 79. Canada transdermal drug delivery systems market, by transdermal semisolids, 2023-2032 (USD Million)
• TABLE 80. Canada transdermal drug delivery systems market, by application, 2018-2022 (USD Million)
• TABLE 81. Canada transdermal drug delivery systems market, by application, 2023 - 2032 (USD Million)
• TABLE 82. Canada transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)
• TABLE 83. Canada transdermal drug delivery systems market, by end-use, 2023 - 2032 (USD Million)
• TABLE 84. Europe transdermal drug delivery systems market, by country, 2018-2022 (USD Million)
• TABLE 85. Europe transdermal drug delivery systems market, by country, 2023 - 2032 (USD Million)
• TABLE 86. Europe transdermal drug delivery systems market, by type, 2018-2022 (USD Million)
• TABLE 87. Europe transdermal drug delivery systems market, by type, 2023 - 2032 (USD Million)
• TABLE 88. Europe transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)
• TABLE 89. Europe transdermal drug delivery systems market, by transdermal patches, 2023-2032 (USD Million)
• TABLE 90. Europe transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)
• TABLE 91. Europe transdermal drug delivery systems market, by transdermal semisolids, 2023-2032 (USD Million)
• TABLE 92. Europe transdermal drug delivery systems market, by application, 2018-2022 (USD Million)
• TABLE 93. Europe transdermal drug delivery systems market, by application, 2023 - 2032 (USD Million)
• TABLE 94. Europe transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)
• TABLE 95. Europe transdermal drug delivery systems market, by end-use, 2023 - 2032 (USD Million)
• TABLE 96. Germany transdermal drug delivery systems market, by type, 2018-2022 (USD Million)
• TABLE 97. Germany transdermal drug delivery systems market, by type, 2023 - 2032 (USD Million)
• TABLE 98. Germany transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)
• TABLE 99. Germany transdermal drug delivery systems market, by transdermal patches, 2023-2032 (USD Million)
• TABLE 100. Germany transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)
• TABLE 101. Germany transdermal drug delivery systems market, by transdermal semisolids, 2023-2032 (USD Million)
• TABLE 102. Germany transdermal drug delivery systems market, by application, 2018-2022 (USD Million)
• TABLE 103. Germany transdermal drug delivery systems market, by application, 2023 - 2032 (USD Million)
• TABLE 104. Germany transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)
• TABLE 105. Germany transdermal drug delivery systems market, by end-use, 2023 - 2032 (USD Million)
• TABLE 106. UK transdermal drug delivery systems market, by type, 2018-2022 (USD Million)
• TABLE 107. UK transdermal drug delivery systems market, by type, 2023 - 2032 (USD Million)
• TABLE 108. UK transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)
• TABLE 109. UK transdermal drug delivery systems market, by transdermal patches, 2023-2032 (USD Million)
• TABLE 110. UK transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)
• TABLE 111. UK transdermal drug delivery systems market, by transdermal semisolids, 2023-2032 (USD Million)
• TABLE 112. UK transdermal drug delivery systems market, by application, 2018-2022 (USD Million)
• TABLE 113. UK transdermal drug delivery systems market, by application, 2023 - 2032 (USD Million)
• TABLE 114. UK transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)
• TABLE 115. UK transdermal drug delivery systems market, by end-use, 2023 - 2032 (USD Million)
• TABLE 116. France transdermal drug delivery systems market, by type, 2018-2022 (USD Million)
• TABLE 117. France transdermal drug delivery systems market, by type, 2023 - 2032 (USD Million)
• TABLE 118. France transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)
• TABLE 119. France transdermal drug delivery systems market, by transdermal patches, 2023-2032 (USD Million)
• TABLE 120. France transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)
• TABLE 121. France transdermal drug delivery systems market, by transdermal semisolids, 2023-2032 (USD Million)
• TABLE 122. France transdermal drug delivery systems market, by application, 2018-2022 (USD Million)
• TABLE 123. France transdermal drug delivery systems market, by application, 2023 - 2032 (USD Million)
• TABLE 124. France transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)
• TABLE 125. France transdermal drug delivery systems market, by end-use, 2023 - 2032 (USD Million)
• TABLE 126. Spain transdermal drug delivery systems market, by type, 2018-2022 (USD Million)
• TABLE 127. Spain transdermal drug delivery systems market, by type, 2023 - 2032 (USD Million)
• TABLE 128. Spain transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)
• TABLE 129. Spain transdermal drug delivery systems market, by transdermal patches, 2023-2032 (USD Million)
• TABLE 130. Spain transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)
• TABLE 131. Spain transdermal drug delivery systems market, by transdermal semisolids, 2023-2032 (USD Million)
• TABLE 132. Spain transdermal drug delivery systems market, by application, 2018-2022 (USD Million)
• TABLE 133. Spain transdermal drug delivery systems market, by application, 2023 - 2032 (USD Million)
• TABLE 134. Spain transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)
• TABLE 135. Spain transdermal drug delivery systems market, by end-use, 2023 - 2032 (USD Million)
• TABLE 136. Italy transdermal drug delivery systems market, by type, 2018-2022 (USD Million)
• TABLE 137. Italy transdermal drug delivery systems market, by type, 2023 - 2032 (USD Million)
• TABLE 138. Italy transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)
• TABLE 139. Italy transdermal drug delivery systems market, by transdermal patches, 2023-2032 (USD Million)
• TABLE 140. Italy transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)
• TABLE 141. Italy transdermal drug delivery systems market, by transdermal semisolids, 2023-2032 (USD Million)
• TABLE 142. Italy transdermal drug delivery systems market, by application, 2018-2022 (USD Million)
• TABLE 143. Italy transdermal drug delivery systems market, by application, 2023 - 2032 (USD Million)
• TABLE 144. Italy transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)
• TABLE 145. Italy transdermal drug delivery systems market, by end-use, 2023 - 2032 (USD Million)
• TABLE 146. Poland transdermal drug delivery systems market, by type, 2018-2022 (USD Million)
• TABLE 147. Poland transdermal drug delivery systems market, by type, 2023 - 2032 (USD Million)
• TABLE 148. Poland transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)
• TABLE 149. Poland transdermal drug delivery systems market, by transdermal patches, 2023-2032 (USD Million)
• TABLE 150. Poland transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)
• TABLE 151. Poland transdermal drug delivery systems market, by transdermal semisolids, 2023-2032 (USD Million)
• TABLE 152. Poland transdermal drug delivery systems market, by application, 2018-2022 (USD Million)
• TABLE 153. Poland transdermal drug delivery systems market, by application, 2023 - 2032 (USD Million)
• TABLE 154. Poland transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)
• TABLE 155. Poland transdermal drug delivery systems market, by end-use, 2023 - 2032 (USD Million)
• TABLE 156. Switzerland transdermal drug delivery systems market, by type, 2018-2022 (USD Million)
• TABLE 157. Switzerland transdermal drug delivery systems market, by type, 2023 - 2032 (USD Million)
• TABLE 158. Switzerland transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)
• TABLE 159. Switzerland transdermal drug delivery systems market, by transdermal patches, 2023-2032 (USD Million)
• TABLE 160. Switzerland transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)
• TABLE 161. Switzerland transdermal drug delivery systems market, by transdermal semisolids, 2023-2032 (USD Million)
• TABLE 162. Switzerland transdermal drug delivery systems market, by application, 2018-2022 (USD Million)
• TABLE 163. Switzerland transdermal drug delivery systems market, by application, 2023 - 2032 (USD Million)
• TABLE 164. Switzerland transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)
• TABLE 165. Switzerland transdermal drug delivery systems market, by end-use, 2023 - 2032 (USD Million)
• TABLE 166. Netherlands transdermal drug delivery systems market, by type, 2018-2022 (USD Million)
• TABLE 167. Netherlands transdermal drug delivery systems market, by type, 2023 - 2032 (USD Million)
• TABLE 168. Netherlands transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)
• TABLE 169. Netherlands transdermal drug delivery systems market, by transdermal patches, 2023-2032 (USD Million)
• TABLE 170. Netherlands transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)
• TABLE 171. Netherlands transdermal drug delivery systems market, by transdermal semisolids, 2023-2032 (USD Million)
• TABLE 172. Netherlands transdermal drug delivery systems market, by application, 2018-2022 (USD Million)
• TABLE 173. Netherlands transdermal drug delivery systems market, by application, 2023 - 2032 (USD Million)
• TABLE 174. Netherlands transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)
• TABLE 175. Netherlands transdermal drug delivery systems market, by end-use, 2023 - 2032 (USD Million)
• TABLE 176. Asia Pacific transdermal drug delivery systems market, by country, 2018-2022 (USD Million)
• TABLE 177. Asia Pacific transdermal drug delivery systems market, by country, 2023 - 2032 (USD Million)
• TABLE 178. Asia Pacific transdermal drug delivery systems market, by type, 2018-2022 (USD Million)
• TABLE 179. Asia Pacific transdermal drug delivery systems market, by type, 2023 - 2032 (USD Million)
• TABLE 180. Asia Pacific transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)
• TABLE 181. Asia Pacific transdermal drug delivery systems market, by transdermal patches, 2023-2032 (USD Million)
• TABLE 182. Asia Pacific transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)
• TABLE 183. Asia Pacific transdermal drug delivery systems market, by transdermal semisolids, 2023-2032 (USD Million)
• TABLE 184. Asia Pacific transdermal drug delivery systems market, by application, 2018-2022 (USD Million)
• TABLE 185. Asia Pacific transdermal drug delivery systems market, by application, 2023 - 2032 (USD Million)
• TABLE 186. Asia Pacific transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)
• TABLE 187. Asia Pacific transdermal drug delivery systems market, by end-use, 2023 - 2032 (USD Million)
• TABLE 188. China transdermal drug delivery systems market, by type, 2018-2022 (USD Million)
• TABLE 189. China transdermal drug delivery systems market, by type, 2023 - 2032 (USD Million)
• TABLE 190. China transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)
• TABLE 191. China transdermal drug delivery systems market, by transdermal patches, 2023-2032 (USD Million)
• TABLE 192. China transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)
• TABLE 193. China transdermal drug delivery systems market, by transdermal semisolids, 2023-2032 (USD Million)
• TABLE 194. China transdermal drug delivery systems market, by application, 2018-2022 (USD Million)
• TABLE 195. China transdermal drug delivery systems market, by application, 2023 - 2032 (USD Million)
• TABLE 196. China transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)
• TABLE 197. China transdermal drug delivery systems market, by end-use, 2023 - 2032 (USD Million)
• TABLE 198. Japan transdermal drug delivery systems market, by type, 2018-2022 (USD Million)
• TABLE 199. Japan transdermal drug delivery systems market, by type, 2023 - 2032 (USD Million)
• TABLE 200. Japan transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)
• TABLE 201. Japan transdermal drug delivery systems market, by transdermal patches, 2023-2032 (USD Million)
• TABLE 202. Japan transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)
• TABLE 203. Japan transdermal drug delivery systems market, by transdermal semisolids, 2023-2032 (USD Million)
• TABLE 204. Japan transdermal drug delivery systems market, by application, 2018-2022 (USD Million)
• TABLE 205. Japan transdermal drug delivery systems market, by application, 2023 - 2032 (USD Million)
• TABLE 206. Japan transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)
• TABLE 207. Japan transdermal drug delivery systems market, by end-use, 2023 - 2032 (USD Million)
• TABLE 208. India transdermal drug delivery systems market, by type, 2018-2022 (USD Million)
• TABLE 209. India transdermal drug delivery systems market, by type, 2023 - 2032 (USD Million)
• TABLE 210. India transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)
• TABLE 211. India transdermal drug delivery systems market, by transdermal patches, 2023-2032 (USD Million)
• TABLE 212. India transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)
• TABLE 213. India transdermal drug delivery systems market, by transdermal semisolids, 2023-2032 (USD Million)
• TABLE 214. India transdermal drug delivery systems market, by application, 2018-2022 (USD Million)
• TABLE 215. India transdermal drug delivery systems market, by application, 2023 - 2032 (USD Million)
• TABLE 216. India transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)
• TABLE 217. India transdermal drug delivery systems market, by end-use, 2023 - 2032 (USD Million)
• TABLE 218. Australia transdermal drug delivery systems market, by type, 2018-2022 (USD Million)
• TABLE 219. Australia transdermal drug delivery systems market, by type, 2023 - 2032 (USD Million)
• TABLE 220. Australia transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)
• TABLE 221. Australia transdermal drug delivery systems market, by transdermal patches, 2023-2032 (USD Million)
• TABLE 222. Australia transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)
• TABLE 223. Australia transdermal drug delivery systems market, by transdermal semisolids, 2023-2032 (USD Million)
• TABLE 224. Australia transdermal drug delivery systems market, by application, 2018-2022 (USD Million)
• TABLE 225. Australia transdermal drug delivery systems market, by application, 2023 - 2032 (USD Million)
• TABLE 226. Australia transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)
• TABLE 227. Australia transdermal drug delivery systems market, by end-use, 2023 - 2032 (USD Million)
• TABLE 228. South Korea transdermal drug delivery systems market, by type, 2018-2022 (USD Million)
• TABLE 229. South Korea transdermal drug delivery systems market, by type, 2023 - 2032 (USD Million)
• TABLE 230. South Korea transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)
• TABLE 231. South Korea transdermal drug delivery systems market, by transdermal patches, 2023-2032 (USD Million)
• TABLE 232. South Korea transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)
• TABLE 233. South Korea transdermal drug delivery systems market, by transdermal semisolids, 2023-2032 (USD Million)
• TABLE 234. South Korea transdermal drug delivery systems market, by application, 2018-2022 (USD Million)
• TABLE 235. South Korea transdermal drug delivery systems market, by application, 2023 - 2032 (USD Million)
• TABLE 236. South Korea transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)
• TABLE 237. South Korea transdermal drug delivery systems market, by end-use, 2023 - 2032 (USD Million)
• TABLE 238. Thailand transdermal drug delivery systems market, by type, 2018-2022 (USD Million)
• TABLE 239. Thailand transdermal drug delivery systems market, by type, 2023 - 2032 (USD Million)
• TABLE 240. Thailand transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)
• TABLE 241. Thailand transdermal drug delivery systems market, by transdermal patches, 2023-2032 (USD Million)
• TABLE 242. Thailand transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)
• TABLE 243. Thailand transdermal drug delivery systems market, by transdermal semisolids, 2023-2032 (USD Million)
• TABLE 244. Thailand transdermal drug delivery systems market, by application, 2018-2022 (USD Million)
• TABLE 245. Thailand transdermal drug delivery systems market, by application, 2023 - 2032 (USD Million)
• TABLE 246. Thailand transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)
• TABLE 247. Thailand transdermal drug delivery systems market, by end-use, 2023 - 2032 (USD Million)
• TABLE 248. Indonesia transdermal drug delivery systems market, by type, 2018-2022 (USD Million)
• TABLE 249. Indonesia transdermal drug delivery systems market, by type, 2023 - 2032 (USD Million)
• TABLE 250. Indonesia transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)
• TABLE 251. Indonesia transdermal drug delivery systems market, by transdermal patches, 2023-2032 (USD Million)
• TABLE 252. Indonesia transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)
• TABLE 253. Indonesia transdermal drug delivery systems market, by transdermal semisolids, 2023-2032 (USD Million)
• TABLE 254. Indonesia transdermal drug delivery systems market, by application, 2018-2022 (USD Million)
• TABLE 255. Indonesia transdermal drug delivery systems market, by application, 2023 - 2032 (USD Million)
• TABLE 256. Indonesia transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)
• TABLE 257. Indonesia transdermal drug delivery systems market, by end-use, 2023 - 2032 (USD Million)
• TABLE 258. Vietnam transdermal drug delivery systems market, by type, 2018-2022 (USD Million)
• TABLE 259. Vietnam transdermal drug delivery systems market, by type, 2023 - 2032 (USD Million)
• TABLE 260. Vietnam transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)
• TABLE 261. Vietnam transdermal drug delivery systems market, by transdermal patches, 2023-2032 (USD Million)
• TABLE 262. Vietnam transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)
• TABLE 263. Vietnam transdermal drug delivery systems market, by transdermal semisolids, 2023-2032 (USD Million)
• TABLE 264. Vietnam transdermal drug delivery systems market, by application, 2018-2022 (USD Million)
• TABLE 265. Vietnam transdermal drug delivery systems market, by application, 2023 - 2032 (USD Million)
• TABLE 266. Vietnam transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)
• TABLE 267. Vietnam transdermal drug delivery systems market, by end-use, 2023 - 2032 (USD Million)
• TABLE 268. MEA transdermal drug delivery systems market, by country, 2018-2022 (USD Million)
• TABLE 269. MEA transdermal drug delivery systems market, by country, 2023 - 2032 (USD Million)
• TABLE 270. MEA transdermal drug delivery systems market, by type, 2018-2022 (USD Million)
• TABLE 271. MEA transdermal drug delivery systems market, by type, 2023 - 2032 (USD Million)
• TABLE 272. MEA transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)
• TABLE 273. MEA transdermal drug delivery systems market, by transdermal patches, 2023-2032 (USD Million)
• TABLE 274. MEA transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)
• TABLE 275. MEA transdermal drug delivery systems market, by transdermal semisolids, 2023-2032 (USD Million)
• TABLE 276. MEA transdermal drug delivery systems market, by application, 2018-2022 (USD Million)
• TABLE 277. MEA transdermal drug delivery systems market, by application, 2023 - 2032 (USD Million)
• TABLE 278. MEA transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)
• TABLE 279. MEA transdermal drug delivery systems market, by end-use, 2023 - 2032 (USD Million)
• TABLE 280. South Africa transdermal drug delivery systems market, by type, 2018-2022 (USD Million)
• TABLE 281. South Africa transdermal drug delivery systems market, by type, 2023 - 2032 (USD Million)
• TABLE 282. South Africa transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)
• TABLE 283. South Africa transdermal drug delivery systems market, by transdermal patches, 2023-2032 (USD Million)
• TABLE 284. South Africa transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)
• TABLE 285. South Africa transdermal drug delivery systems market, by transdermal semisolids, 2023-2032 (USD Million)
• TABLE 286. South Africa transdermal drug delivery systems market, by application, 2018-2022 (USD Million)
• TABLE 287. South Africa transdermal drug delivery systems market, by application, 2023 - 2032 (USD Million)
• TABLE 288. South Africa transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)
• TABLE 289. South Africa transdermal drug delivery systems market, by end-use, 2023 - 2032 (USD Million)
• TABLE 290. Saudi Arabia transdermal drug delivery systems market, by type, 2018-2022 (USD Million)
• TABLE 291. Saudi Arabia transdermal drug delivery systems market, by type, 2023 - 2032 (USD Million)
• TABLE 292. Saudi Arabia transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)
• TABLE 293. Saudi Arabia transdermal drug delivery systems market, by transdermal patches, 2023-2032 (USD Million)
• TABLE 294. Saudi Arabia transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)
• TABLE 295. Saudi Arabia transdermal drug delivery systems market, by transdermal semisolids, 2023-2032 (USD Million)
• TABLE 296. Saudi Arabia transdermal drug delivery systems market, by application, 2018-2022 (USD Million)
• TABLE 297. Saudi Arabia transdermal drug delivery systems market, by application, 2023 - 2032 (USD Million)
• TABLE 298. Saudi Arabia transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)
• TABLE 299. Saudi Arabia transdermal drug delivery systems market, by end-use, 2023 - 2032 (USD Million)
• TABLE 300. UAE transdermal drug delivery systems market, by type, 2018-2022 (USD Million)
• TABLE 301. UAE transdermal drug delivery systems market, by type, 2023 - 2032 (USD Million)
• TABLE 302. UAE transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)
• TABLE 303. UAE transdermal drug delivery systems market, by transdermal patches, 2023-2032 (USD Million)
• TABLE 304. UAE transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)
• TABLE 305. UAE transdermal drug delivery systems market, by transdermal semisolids, 2023-2032 (USD Million)
• TABLE 306. UAE transdermal drug delivery systems market, by application, 2018-2022 (USD Million)
• TABLE 307. UAE transdermal drug delivery systems market, by application, 2023 - 2032 (USD Million)
• TABLE 308. UAE transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)
• TABLE 309. UAE transdermal drug delivery systems market, by end-use, 2023 - 2032 (USD Million)
• TABLE 310. Israel transdermal drug delivery systems market, by type, 2018-2022 (USD Million)
• TABLE 311. Israel transdermal drug delivery systems market, by type, 2023 - 2032 (USD Million)
• TABLE 312. Israel transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)
• TABLE 313. Israel transdermal drug delivery systems market, by transdermal patches, 2023-2032 (USD Million)
• TABLE 314. Israel transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)
• TABLE 315. Israel transdermal drug delivery systems market, by transdermal semisolids, 2023-2032 (USD Million)
• TABLE 316. Israel transdermal drug delivery systems market, by application, 2018-2022 (USD Million)
• TABLE 317. Israel transdermal drug delivery systems market, by application, 2023 - 2032 (USD Million)
• TABLE 318. Israel transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)
• TABLE 319. Israel transdermal drug delivery systems market, by end-use, 2023 - 2032 (USD Million)

Charts & Figures

• FIG. 1 GMI report coverage: Critical research elements
• FIG. 2 Industry segmentation
• FIG. 3 Top-down approach
• FIG. 4 Market estimation and forecast methodology
• FIG. 5 Market forecasting methodology
• FIG. 6 Breakdown of primary participants
• FIG. 7 Global transdermal drug delivery systems industry 360 degree synopsis, 2018 - 2032 (USD Mn)
• FIG. 8 Growth potential analysis, by type
• FIG. 9 Growth potential analysis, by application
• FIG. 10 Growth potential analysis, by end-use
• FIG. 11 Company matrix analysis
• FIG. 12 Strategic dashboard
• FIG. 13 Competitive analysis of major market players
• FIG. 14 Competitive positioning matrix
• FIG. 15 Strategic outlook matrix

Global Transdermal Drug Delivery System Market is expected to exhibit a decent CAGR from 2023 to 2032, owing to the rising demand for non-invasive drug delivery systems. Oral, topical, transdermal, and other non-invasive drug delivery methods are painless and demonstrate fewer side effects than invasive procedures. These attributes have added to the popularity of these systems over the years and boosted their adoption among patients with higher dependency on self-administration and improved patient compliance due to reduced dosing frequencies.

The overall transdermal drug delivery system market is categorized on the basis of type, application, end-use, and region.

Regarding the type, the transdermal drug delivery system market size from the semisolids segment is anticipated to garner commendable gains through 2032. Semisolid transdermal drug delivery products such as sprays enable direct drug delivery and have lesser side effects. Additionally, they help administer pre-measured doses in patients for better treatment. Moreover, the high availability of a wide range of semi-solid transdermal drug delivery products such as ointment, gels, sprays, and others will favor their adoption through 2032.

With respect to application, the cardiovascular diseases segment accumulated over 19% market share in 2022. High prevalence rate of cardiovascular disorders (CVDs) globally will increase product uptake in the forthcoming years. As per WHO, CVDs are a prominent cause of death, resulting in around 17.9 million mortalities across the globe annually. Moreover, the increased acceptance of non-invasive drug delivery devices for the treatment of these diseases will further create a strong growth outlook for the transdermal drug delivery system market.

Based on end-use, the transdermal drug delivery system industry from home care settings segment could record a decent valuation by 2032. Recent innovations in transdermal drug delivery systems have fostered their adoption in home care applications. These drug delivery systems reduce the risks and discomfort associated with the parenteral route of administration, making them suitable for home usage. This apart, the increasing demand for minimally invasive treatment will further contribute to strong product demand in the long run.

Asia Pacific transdermal drug delivery system market is poised to expand substantially through 2032. Rising geriatric population and its higher susceptibility to chronic disorders have increased the demand for transdermal drug delivery systems in the region. According to WHO, 28% of the total population in China will be above 60 years by 2040. Asia Pacific is also home to key industry players such as Hisamitsu Pharmaceutical Co., Inc. and others constantly indulged in product innovations. This will also have a positive impact on the overall market dynamics in the coming years.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Industry coverage
• 1.2 Market scope and definitions
• 1.3 Base estimates and working
  • 1.3.1 Data collection
• 1.4 Forecast parameters
• 1.5 COVID-19 impact analysis at global level
• 1.6 Data validation
• 1.7 Data sources
  • 1.7.1 Primary
  • 1.7.2 Secondary
    • 1.7.2.1 Paid sources
    • 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

• 2.1 Transdermal drug delivery systems industry 360 degree synopsis, 2018 - 2032
  • 2.1.1 Business trends
  • 2.1.2 Type trends
  • 2.1.3 Application trends
  • 2.1.4 End-use trends
  • 2.1.5 Regional trends

Chapter 3 Transdermal Drug Delivery Systems Industry Insights

• 3.1 Industry segmentation
• 3.2 Industry landscape, 2018 - 2032
• 3.3 Industry impact forces
  • 3.3.1 Growth drivers
    • 3.3.1.1 Increasing prevalence of chronic diseases
    • 3.3.1.2 Increasing adoption of transdermal patches
    • 3.3.1.3 Growing demand for non-invasive drug delivery system
  • 3.3.2 Industry pitfalls & challenges
    • 3.3.2.1 Limited number of approved medications
    • 3.3.2.2 High cost involved in development of drug delivery systems
• 3.4 Growth potential analysis
  • 3.4.1 By type
  • 3.4.2 By application
  • 3.4.3 By end-use
• 3.5 COVID-19 impact analysis
• 3.6 Regulatory landscape
• 3.7 Advancement in transdermal drug delivery systems
• 3.8 Transdermal forms containing the specified active substance, %
• 3.9 Pricing analysis, by type, 2022
• 3.10 Porter's analysis
• 3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2021

• 4.1 Introduction
• 4.2 Company matrix analysis, 2021
• 4.3 Company positioning matrix
• 4.4 Competitive analysis of major market players
• 4.5 Strategic outlook matrix
• 4.6 Strategy dashboard, 2021

Chapter 5 Transdermal Drug Delivery Systems Market, By Type

• 5.1 Key type trends
• 5.2 Transdermal patches
  • 5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.2.2 Drug-in-adhesive patches
    • 5.2.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.2.3 Matrix patches
    • 5.2.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.2.4 Reservoir membrane patches
    • 5.2.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.2.5 Microneedle patches
    • 5.2.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 5.3 Transdermal semisolids
  • 5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.3.2 Gels
    • 5.3.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.3.3 Ointments
    • 5.3.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.3.4 Sprays
    • 5.3.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 6 Transdermal Drug Delivery Systems Market, By Application

• 6.1 Key application trends
• 6.2 Pain management
  • 6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 6.3 Hormonal application
  • 6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 6.4 Central nervous system disorders
  • 6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 6.5 Cardiovascular diseases
  • 6.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 6.6 Others
  • 6.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7 Transdermal Drug Delivery Systems Market, By End-use

• 7.1 Key end-use trends
• 7.2 Hospitals
  • 7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 7.3 Clinics
  • 7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 7.4 Homecare settings
  • 7.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 7.5 Others
  • 7.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 8 Transdermal Drug Delivery Systems Market, By Region

• 8.1 Key regional trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Italy
  • 8.3.5 Spain
  • 8.3.6 Poland
  • 8.3.7 Switzerland
  • 8.3.8 The Netherlands
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Indonesia
  • 8.4.7 Thailand
  • 8.4.8 Vietnam
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Peru
  • 8.5.5 Colombia
• 8.6 Middle East & Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE
  • 8.6.4 Israel

Chapter 9 Company Profiles

• 9.1 Novartis
• 9.2 Mylan
• 9.3 Amneal Pharmaceuticals, Inc
• 9.4 Zydus Pharmaceuticals, Inc
• 9.5 UCB
• 9.6 Hisamitsu Pharmaceutical Co.,Inc
• 9.7 Corium, Inc.
• 9.8 Micropoint Technologies.
• 9.9 Sparsha Pharma International Pvt. Ltd.
• 9.10 Luye pharma